Clinical Trial Update: A Study of Sinotecean on Tolerance and Pharmacokinetics [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update on Sinotecean evaluating tolerance and pharmacokinetics in patients with advanced cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Sinotecean

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Advanced Cancer | Phase 1 | Status: UNKNOWN